Acurx Pharmaceuticals, Inc. (ACXP)
Nasdaq: ACXP · Pharmaceutical Preparations · Staten Island, NY · filing with the SEC since 2018
Who runs Acurx Pharmaceuticals, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Luci David P
President and CEO. First filing Jun 2021, latest Apr 22, 2026, 3 filings in all.
Officers reporting now
2
of 8 people with a filing in the last fifteen months
Directors reporting now
6
8 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Luci David P | President and CEO | Jun 2021 | Apr 22, 2026 | none |
| Shawah Robert G. | Chief Financial Officer | Jun 2021 | Apr 22, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Dean Jack H | director | Jun 2021 | Apr 22, 2026 | none |
| Deluccia Robert J | director | Jun 2021 | Apr 22, 2026 | none |
| Donohue James J. | director | Jun 2021 | Apr 22, 2026 | none |
| Harrison Thomas L | director | Jun 2021 | Apr 22, 2026 | none |
| Sailer Carl | director | Jun 2021 | Apr 22, 2026 | none |
| Scodari Joseph C | director | Jun 2021 | Apr 22, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.